Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.400
+0.030 (2.19%)
Sep 16, 2025, 11:55 AM EDT - Market open
Cibus Market Cap
Cibus has a market cap or net worth of $75.93 million as of September 16, 2025. Its market cap has decreased by -51.79% in one year.
Market Cap
75.93M
Enterprise Value
289.75M
1-Year Change
-51.79%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $299.25M to $75.93M, a decrease of -74.63%. That is a compound annual growth rate of -15.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 71.98M | -2.13% |
| Dec 31, 2024 | 73.55M | -80.23% |
| Dec 29, 2023 | 372.10M | 5,065.15% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.02M | -47.56% |
| Dec 31, 2020 | 156.41M | -32.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |